Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Nov;89(3):525–532. doi: 10.1111/j.1476-5381.1986.tb11152.x

Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in the rat isolated aorta.

I Alosachie, T Godfraind
PMCID: PMC1917145  PMID: 3026546

Abstract

The effect of endothelium on the adrenolytic action of prazosin was studied in the rat isolated aorta. Prazosin showed a non-competitive type of antagonism in preparations with intact endothelium while in preparations where endothelium had been removed, prazosin at concentrations between 0.3 nM-10 nM acted as a competitive antagonist. Methylene blue, used to decrease tissue levels of guanosine 3':5'-cyclic monophosphate (cyclic GMP), converted prazosin from a non-competitive antagonist into an apparently competitive antagonist in the presence of endothelium. Increasing tissue levels of cyclic GMP by incubation with 8-bromo-cyclic GMP converted prazosin from an apparently competitive antagonist into a non-competitive antagonist in the absence of endothelium. Analysis of concentration-response curves for noradrenaline in the presence and absence of endothelium showed that the affinity for noradrenaline was the same but the efficacy, measured by estimating the receptor reserve, was not; it was lower in the presence than in the absence of endothelium. It was concluded that the change in the mode of antagonism of prazosin after endothelium removal could be related to an alteration in the efficacy of the agonist, brought about by a change in the tissue levels of cyclic GMP.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIENS E. J., VAN ROSSUM J. M. pDx, pAx and pDx values in the analysis of pharmacodynamics. Arch Int Pharmacodyn Ther. 1957 Apr 1;110(2-3):275–299. [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bigaud M., Schoeffter P., Stoclet J. C., Miller R. C. Dissociation between endothelium-mediated increases in tissue cGMP levels and modulation of aortic contractile responses. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):221–223. doi: 10.1007/BF00512078. [DOI] [PubMed] [Google Scholar]
  4. Bkaily G., Sperelakis N. Injection of guanosine 5'-cyclic monophosphate into heart cells blocks calcium slow channels. Am J Physiol. 1985 May;248(5 Pt 2):H745–H749. doi: 10.1152/ajpheart.1985.248.5.H745. [DOI] [PubMed] [Google Scholar]
  5. Carman-Krzan M. Role of endothelium in the binding of [3H]prazosin to the aortic alpha 1-adrenergic receptors. Eur J Pharmacol. 1985 Apr 23;111(1):137–138. doi: 10.1016/0014-2999(85)90124-4. [DOI] [PubMed] [Google Scholar]
  6. Carrier G. O., White R. E. Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta. J Pharmacol Exp Ther. 1985 Mar;232(3):682–687. [PubMed] [Google Scholar]
  7. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  8. Cohen M. L., Wiley K. S., Slater I. H. In vitro relaxation of arteries and veins by prazosin: alpha-adrenergic blockade with no direct vasodilation. Blood Vessels. 1979;16(3):144–154. doi: 10.1159/000158201. [DOI] [PubMed] [Google Scholar]
  9. Diamond J., Chu E. B. Possible role for cyclic GMP in endothelium-dependent relaxation of rabbit aorta by acetylcholine. Comparison with nitroglycerin. Res Commun Chem Pathol Pharmacol. 1983 Sep;41(3):369–381. [PubMed] [Google Scholar]
  10. Digges K. G., Summers R. J. Characterization of postsynaptic alpha-adrenoceptors in rat aortic strips and portal veins. Br J Pharmacol. 1983 Jul;79(3):655–665. doi: 10.1111/j.1476-5381.1983.tb10002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Downing O. A., Wilson K. A., Wilson V. G. Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. Br J Pharmacol. 1983 Oct;80(2):315–322. doi: 10.1111/j.1476-5381.1983.tb10036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eglème C., Godfraind T., Miller R. C. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol. 1984 Jan;81(1):16–18. doi: 10.1111/j.1476-5381.1984.tb10736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fortes Z. B., Garcia Leme J., Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol. 1983 Jul;79(3):771–781. doi: 10.1111/j.1476-5381.1983.tb10016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Furchgott R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol. 1984;24:175–197. doi: 10.1146/annurev.pa.24.040184.001135. [DOI] [PubMed] [Google Scholar]
  15. Godfraind T. Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. J Pharmacol Exp Ther. 1983 Feb;224(2):443–450. [PubMed] [Google Scholar]
  16. Godfraind T., Egleme C., Al Osachie I. Role of endothelium in the contractile response of rat aorta to alpha-adrenoceptor agonists. Clin Sci (Lond) 1985;68 (Suppl 10):65s–71s. doi: 10.1042/cs068s065. [DOI] [PubMed] [Google Scholar]
  17. Hamed A. T., Johnson T. D., Charlton K. G., Clarke D. E. Pharmacological characterization of alpha-adrenoreceptor subtypes in rat isolated thoracic aorta. J Auton Pharmacol. 1983 Dec;3(4):265–273. doi: 10.1111/j.1474-8673.1983.tb00544.x. [DOI] [PubMed] [Google Scholar]
  18. Holzmann S. Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucleotide Res. 1982;8(6):409–419. [PubMed] [Google Scholar]
  19. Ignarro L. J., Kadowitz P. J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol. 1985;25:171–191. doi: 10.1146/annurev.pa.25.040185.001131. [DOI] [PubMed] [Google Scholar]
  20. Konishi M., Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 1983 Nov-Dec;5(6):881–886. doi: 10.1161/01.hyp.5.6.881. [DOI] [PubMed] [Google Scholar]
  21. Lincoln T. M. Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta. J Pharmacol Exp Ther. 1983 Jan;224(1):100–107. [PubMed] [Google Scholar]
  22. Lues I., Schümann H. J. Effect of removing the endothelial cells on the reactivity of rat aortic segments to different alpha-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):160–163. doi: 10.1007/BF00512066. [DOI] [PubMed] [Google Scholar]
  23. Malta E., Schini V., Miller R. C. Role of efficacy in the assessment of the actions of alpha-adrenoceptor agonists in rat aorta with endothelium. J Pharm Pharmacol. 1986 Mar;38(3):209–213. doi: 10.1111/j.2042-7158.1986.tb04545.x. [DOI] [PubMed] [Google Scholar]
  24. Miller R. C., Mony M., Schini V., Schoeffter P., Stoclet J. C. Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol. 1984 Dec;83(4):903–908. doi: 10.1111/j.1476-5381.1984.tb16530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Morel N., Wibo M., Godfraind T. A calmodulin-stimulated Ca2+ pump in rat aorta plasma membranes. Biochim Biophys Acta. 1981 Jun 9;644(1):82–88. doi: 10.1016/0005-2736(81)90061-4. [DOI] [PubMed] [Google Scholar]
  26. Napoli S. A., Gruetter C. A., Ignarro L. J., Kadowitz P. J. Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. J Pharmacol Exp Ther. 1980 Mar;212(3):469–473. [PubMed] [Google Scholar]
  27. Pfitzer G., Hofmann F., DiSalvo J., Rüegg J. C. cGMP and cAMP inhibit tension development in skinned coronary arteries. Pflugers Arch. 1984 Jul;401(3):277–280. doi: 10.1007/BF00582596. [DOI] [PubMed] [Google Scholar]
  28. Rapoport R. M., Draznin M. B., Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 1983 Nov 10;306(5939):174–176. doi: 10.1038/306174a0. [DOI] [PubMed] [Google Scholar]
  29. Schultz K. D., Böhme E., Kreye V. A., Schultz G. Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jan;306(1):1–9. doi: 10.1007/BF00515586. [DOI] [PubMed] [Google Scholar]
  30. Suematsu E., Hirata M., Kuriyama H. Effects of cAMP- and cGMP-dependent protein kinases, and calmodulin on Ca2+ uptake by highly purified sarcolemmal vesicles of vascular smooth muscle. Biochim Biophys Acta. 1984 Jun 13;773(1):83–90. doi: 10.1016/0005-2736(84)90552-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES